Lung cancer 2011 talk-for 17-10-2011-17-10-2011
©2004 Millennium Pharmaceuticals, Inc. © 2004 Millennium Pharmaceuticals Inc. Opportunities and Challenges in Utilizing Biomarkers for Drug Development.
Analysis of the Epidermal Growth Factor Receptor and K-Ras genes in patients with Non-small Cell Lung Cancer H. Mugalaasi 1, J. Davies 2, L Medley 2, D.
Cytology Paris 2013: presentation selected for a cytopathologist junior prize
32nd Annual Oncology Nurses Symposium
2012 AACR poster
PARAMOUNT: phase III study of pemetrexed continuation maintenance therapy in advanced non-squamous NSCLC.
Cost-Effectiveness FDG-PET in Lung Cancer Staging.
IV REUNIÓN GIDO-GGCP Dr. José Muñoz Langa Servicio Oncología Médica Hospital Universitario y Politécnico La Fe Inmunoterapia en Cáncer de Pulmón Baiona,
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC Beth Eaby-Sandy, MSN, CRNP, OCN ® Nurse Practitioner Abramson Cancer.
Experience and Outcomes with Hypofractionated Concurrent Chemoradiation for Stage III NSCLC at NCCC Gregory Webb Medical Student.
1 Copyright 2008 Genoptix, Inc. Mike Nerenberg, MD CTO & Sr. VP Business Development Genoptix, Inc. B.A. University of Chicago M.D. Yale University School.
